Response to ibrutinib varies by DLBCL subtypeJuly 21, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Ibrutinib approved to treat WM in EUJuly 11, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Early progression predicts overall survival in FLJuly 9, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Novel mAb targeting CD70 shows activity in TCLJuly 8, 2015Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin Lymphoma
NICE wants more info on PI3Kδ inhibitorJuly 8, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Novel SYK inhibitor shows ‘good early evidence’ of activityJuly 5, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
PI3Kδ/γ inhibitor generates rapid responses in CLLJuly 2, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Drug can produce durable responses in rel/ref PTCLJuly 1, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
‘Radically different’ PI3Kδ inhibitor lacks hepatotoxicityJune 30, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin Lymphoma
Insecticide can cause NHL, experts sayJune 29, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Nivolumab produces ‘dramatic’ responses in HLJune 25, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHodgkin LymphomaCMLNon-Hodgkin Lymphoma
Targeted agent shows early promise for NHLJune 25, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
EZH2 inhibitor proves active in rel/ref NHLJune 23, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
